Biolife Solutions Inc Inventory Turnover Ratio (COS)

Cost of Sales Formula, Quarterly Results, Trends, Rankings, Statistics

Biolife Solutions Inc inventory turnover ratio, the Biolife Solutions Inc 's ability to sell and replace its inventory in the first quarter 2026, sequentially increased to 1.25 in the first quarter 2026, yet the ratio remained below the average, as BLFS's market remain challenging.Average inventory processing period, for the Biolife Solutions Inc in Mar 31 2026 quarter, has decreased to 292 days, compare to 304 days, in the Dec 31 2025 quarter.

Within Healthcare sector 289 other companies have achieved higher inventory turnover ratio. While Inventory turnover ratio total ranking has improved so far during the I Quarter 2026, to 1160, from total ranking in the fourth quarter 2025 at 1270.

BLFS Inventory Turnover Ratio using Sales Formula
What is Inventory Turnover Ratio?
What is Biolife Solutions Inc Market Share?

What is Inventory Turnover Ratio?

Select the Comparisons :

None ▼

Select the Ratio:

Inventory Turnover▼

None ▼

Inventory Turnover▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

BLFS Inventory Turnover Ratio	(Mar 31 2026) I. Quarter	(Dec 31 2025) IV. Quarter	(Sep 30 2025) III. Quarter	(Jun 30 2025) II. Quarter	(Mar 31 2025) I. Quarter
Y / Y Inventory Growth	19.11 %	3.94 %	-13.53 %	-14.79 %	-36.5 %
Y / Y Cost of Sales Growth	40.67 %	31.77 %	5.97 %	-6.72 %	-50.58 %
Inventory Turnover Ratio (TTM)	1.25	1.2	1.13	1.07	1.05
BLFS's Total Ranking	# 1160	# 1270	# 1570	# 1377	# 1341
Average inventory processing period	293	304	323	341	348
Seq. Inventory Growth	8.88 %	8.37 %	0.49 %	0.45 %	-4.99 %
Seq. Cost of Sales Growth	4.52 %	3.01 %	15.59 %	13.03 %	-2.09 %

Inventory Turnover Ratio Company Ranking
Within:	No.
Medical Equipment & Supplies Industry	# 133
Healthcare Sector	# 290
Overall Market	# 1160

Inventory Turnover Ratio Statistics
High	Average	Low
15.33	3.09	1.05
(Mar 31 2014)		(Mar 31 2025)

BLFS Company Profile >> Back to BLFS Efficiency Comparisons >> Compare BLFS Inventory Turnover Ratio to its Competitors

Financial Statements
Biolife Solutions Inc 's Inventories	$ 33 Millions	Visit BLFS's Balance sheet
Biolife Solutions Inc 's Cost of Revenues TTM	$ 37 Millions	Visit BLFS's Income Statement
What are BLFS's Sales?		Visit BLFS's Sales by Segment

Other Inventory Turnover Ratios
Biolife Solutions Inc 's Inventory to Sales Ratio
U.S. Durable Goods Inventory to Shipment Ratio By Product
Medical Equipment & Supplies Industry Inventory Turnover Trends and Statistics
Healthcare Sector Inventory Turnover Statistics
Inventory Turnover Trends for overall market
BLFS's Inventory Turnover Ratio versus Medical Equipment & Supplies Industry, Healthcare Sector and total Market
Highest Ranking Inventory Turnover
Lowest Ranking Inventory Turnover
Inventory Turnover for BLFS's Competitors
Inventory Turnover Ratio for BLFS's Suppliers
Inventory Turnover Ratio for BLFS's Customers

You may also want to know
BLFS's Sales Growth Rates	BLFS's Pe Price to earnings ratio	BLFS's Receivables Turnover Ratio	BLFS's Stock Quote
BLFS's Net Income Growth Rates	BLFS's Ps Price to Sales ratio	BLFS's Sales per Employee	BLFS's Asset Turnover Ratio
BLFS's Net Margin	BLFS's Pb Price to Book ratio	BLFS's Financial Strength Ratios	BLFS's Dividend Payout Ratio

Companies with similar Inventory Turnover Ratio for the quarter ending Mar 31 2026, within Healthcare Sector	Inventory Turnover Ratio	Cost of revenues at quarter ending Mar 31 2026	Inventories at quarter ending Mar 31 2026
Beyond Air Inc	3.07	$ 6.521 Millions	$ 2 Millions
Bausch Health Companies Inc	3.07	$ 2,987.000 Millions	$ 974 Millions
Indivior Pharmaceuticals Inc	3.03	$ 242.000 Millions	$ 80 Millions
Amneal Pharmaceuticals Inc	3.02	$ 1,868.000 Millions	$ 618 Millions
Logicmark Inc	3.01	$ 3.826 Millions	$ 1 Millions
Mettler toledo International Inc	3.01	$ 1,189.678 Millions	$ 395 Millions
Revvity Inc	3.00	$ 1,151.379 Millions	$ 384 Millions
Cannapharmarx Inc	2.98	$ 2.921 Millions	$ 1 Millions
Becton Dickinson And Company	2.97	$ 11,368.000 Millions	$ 3,821 Millions
Dexcom Inc	2.97	$ 1,854.000 Millions	$ 624 Millions
Msa Safety Inc	2.93	$ 1,020.000 Millions	$ 349 Millions
Nexgel Inc	2.92	$ 6.000 Millions	$ 2 Millions
Abbott Laboratories	2.91	$ 19,741.000 Millions	$ 6,785 Millions
Zai Lab Limited	2.91	$ 128.112 Millions	$ 44 Millions
Mimedx Group Inc	2.87	$ 74.000 Millions	$ 26 Millions
Dentsply Sirona Inc	2.82	$ 1,880.000 Millions	$ 666 Millions
Catalyst Pharmaceuticals Inc	2.82	$ 83.817 Millions	$ 30 Millions
Evofem Biosciences Inc	2.82	$ 4.662 Millions	$ 2 Millions
Livanova Plc	2.80	$ 464.684 Millions	$ 166 Millions
Orthofix Medical Inc	2.79	$ 242.580 Millions	$ 87 Millions
Lifecore Biomedical Inc	2.76	$ 89.000 Millions	$ 32 Millions
Zeo Scientifix Inc	2.76	$ 1.291 Millions	$ 0 Millions
Akebia Therapeutics Inc	2.76	$ 44.127 Millions	$ 16 Millions
Biomerica Inc	2.72	$ 4.142 Millions	$ 2 Millions
Nephros Inc	2.71	$ 8.000 Millions	$ 3 Millions
Neogen Corporation	2.70	$ 478.000 Millions	$ 177 Millions
Merck and Co Inc	2.62	$ 17,158.000 Millions	$ 6,546 Millions
Ligand Pharmaceuticals Incorporated	2.62	$ 32.548 Millions	$ 12 Millions
Electrocore Inc	2.57	$ 4.012 Millions	$ 2 Millions
Anika Therapeutics Inc	2.57	$ 48.000 Millions	$ 19 Millions

Date modified: 2026-08-29T17:21:34+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.